The Myelofibrosis Symptom Burden (MF-SB): An International Phenotypic Cluster Analysis of 329 Patients
Holly L. Geyer(Mayo Clinic Hospital), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Jean‐Jacques Kiladjian(Délégation Paris 5), Francesco Passamonti(University of Milan), Frank Stegelmann(University Hospital Ulm), Pablo Muxí(Hospital Británico), Gunnar Birgegård(Uppsala University Hospital), Jean-Christophe Lanotto, Xiujuan Sun(Chinese Academy of Sciences), Heike L. Pahl(University Medical Center Freiburg), Ayalew Tefferi(Mayo Clinic), Francisco Cervantes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Carlos Besses(Hospital Del Mar), Dolores Hernández‐Maraver(Centre Hospitalier Universitaire de Grenoble), Andreas Reiter(Heidelberg University), Thomas Lehmann(University of Basel), Deepti Radia(St Thomas' Hospital), Harry C. Schouten, Jean‐Yves Cahn, Konstanze Doehner(University Hospital Ulm), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Jan Samuelsson(Karolinska University Hospital), Yue Zhang(Hubei University of Medicine), Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Federico Sackmann(Centre Hospitalier Universitaire de Grenoble), Peter A.W. te Boekhorst(Erasmus MC), Zhijian Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Stefanie Slot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Gabriel Étienne(Institut Bergonié), Maria L Ferarri(Centre Hospitalier Universitaire de Grenoble), Karin Bonatz(Centre Hospitalier Universitaire de Grenoble), Suzan Commandeur(Leiden University), Dana Ranta(Centre Hospitalier Régional et Universitaire de Nancy), Robyn M. Emanuel(Centre Hospitalier Universitaire de Grenoble), Sonja Zweegman(Vrije Universiteit Amsterdam), Robert Peter Gale(Imperial College London), Giovanni Barosi(Policlinico San Matteo Fondazione), Amylou C. Dueck(Mayo Clinic in Arizona), Junqing Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Peihong Zhang(Tongji University), Peter Johansson(Sahlgrenska University Hospital), Norman I Maldonado(University of Puerto Rico System), Françoise Boyer(Centre Hospitalier Universitaire d'Angers), Martin Grießhammer(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Ana Kerguelen Fuentes(Centre Hospitalier Universitaire de Grenoble), Lydia Roy(Centre Hospitalier Universitaire de Poitiers)
Cited by 5
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k